Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
Elina Kilpi-Jakonen, Assistant professor, Scientific programme co-ordinator at the University of Turku, discusses the development of social inequalities across labour market careers.
F Barry Dunning and Thomas C Killian from the Department of Physics & Astronomy at Rice University depict the benefits of research into the remarkable physical and chemical properties of Rydberg atoms.
Joli Rumi Borah and Terry Sunderland from the Faculty of Forestry, University of British Columbia, discuss how forests and trees play a crucial role in sustaining agriculture.
Here, Professor Kayoko Ito tells us about her ongoing research into foster care in the UK, using the results to assess the best way to increase fostering in Japan.
Laura Kirschbacher, Corporate Communications, Pfalzklinikum, details how to establish HR marketing within a health organisation, in this project report.
A new editorial, published across 220 journals, expresses the climate concerns of healthcare professionals and researchers - with Dr Ghebreyesus saying "there is no vaccine for the climate crisis".
CEO of Dxcover Limited, Mark Hegarty, offers an insight into their cutting-edge technology that can help save lives by detecting early signs of cancer.
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
Kim, Chang-Soo from Missouri University of Science and Technology with Stoecker, William V from Stoecker & Associates Technology, Rolla, Missouri, describe a breakthrough smart bandage by S&A Tech and Missouri S&T capable of detecting low tissue oxygen.
In a study spanning fifty years, researchers reveal that transgender people still face a disproportionate likelihood of death - a likelihood not connected to gender-affirming hormone treatment.
